Viewing Study NCT01627002


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2026-01-09 @ 7:12 PM
Study NCT ID: NCT01627002
Status: TERMINATED
Last Update Posted: 2013-09-23
First Post: 2012-06-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase 1, First in Human Study to Investigate the Safety and Tolerability of PA401
Sponsor: ProtAffin Biotechnologie AG
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: PA401/01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators